Identification of novel interacts partners of ADAR1 enzyme mediating the oncogenic process in aggressive breast cancer

Triple-negative breast cancer (TNBC) subtype is characterized by aggressive clinical behavior and poor prognosis patient outcomes. Here, we show that ADAR1 is more abundantly expressed in infiltrating breast cancer (BC) tumors than in benign tumors. Further, ADAR1 protein expression is higher in agg...

Descripción completa

Detalles Bibliográficos
Autores principales: Binothman, Najat, Aljadani, Majidah, Alghanem, Bandar, Refai, Mohammed Y., Rashid, Mamoon, Al Tuwaijri, Abeer, Alsubhi, Nouf H., Alrefaei, Ghadeer I., Khan, Muhammad Yasir, Sonbul, Sultan N., Aljoud, Fadwa, Alhayyani, Sultan, Abdulal, Rwaa H., Ganash, Magdah, Hashem, Anwar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206070/
https://www.ncbi.nlm.nih.gov/pubmed/37221310
http://dx.doi.org/10.1038/s41598-023-35517-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206070/
https://www.ncbi.nlm.nih.gov/pubmed/37221310
http://dx.doi.org/10.1038/s41598-023-35517-6

Ejemplares similares